SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-09-032164
Filing Date
2009-08-07
Accepted
2009-08-07 16:41:47
Documents
8
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y78698e10vq.htm 10-Q 436777
2 EX-10.1 y78698exv10w1.htm EX-10.1 280613
3 EX-10.2 y78698exv10w2.htm EX-10.2 25282
4 EX-10.3 y78698exv10w3.htm EX-10.3 186213
5 EX-31.1 y78698exv31w1.htm EX-31.1 6356
6 EX-31.2 y78698exv31w2.htm EX-31.2 6658
7 EX-32.1 y78698exv32w1.htm EX-32.1 2935
8 EX-32.2 y78698exv32w2.htm EX-32.2 3042
  Complete submission text file 0000950123-09-032164.txt   949372
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15190 | Film No.: 09996248
SIC: 2835 In Vitro & In Vivo Diagnostic Substances